/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy
Event: ESC Congress 2019
Topic: Revascularisation
Session: Innovative strategies in percutaneous coronary intervention
ESC 365 is supported by
